Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability von Halton, J. M. L., Albisetti, M., Biss, B., Bomgaars, L., Brueckmann, M., Gropper, S., Harper, R., Huang, F., Luciani, M., Maas, H., Tartakovsky, I., Mitchell, L. G.

Volltext

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial von Voors, Adriaan A., Angermann, Christiane E., Teerlink, John R., Collins, Sean P., Kosiborod, Mikhail, Biegus, Jan, Ferreira, João Pedro, Nassif, Michael E., Psotka, Mitchell A., Tromp, Jasper, Borleffs, C. Jan Willem, Ma, Changsheng, Comin-Colet, Joseph, Fu, Michael, Janssens, Stefan P., Kiss, Robert G., Mentz, Robert J., Sakata, Yasushi, Schirmer, Henrik, Schou, Morten, Schulze, P. Christian, Spinarova, Lenka, Volterrani, Maurizio, Wranicz, Jerzy K., Zeymer, Uwe, Zieroth, Shelley, Brueckmann, Martina, Blatchford, Jonathan P., Salsali, Afshin, Ponikowski, Piotr

Volltext

Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation von Sinnaeve, P. R., Brueckmann, M., Clemens, A., Oldgren, J., Eikelboom, J., Healey, J. S.

Volltext

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source von Diener, Hans-Christoph, Sacco, Ralph L, Easton, J. Donald, Granger, Christopher B, Bernstein, Richard A, Uchiyama, Shinichiro, Kreuzer, Jörg, Cronin, Lisa, Cotton, Daniel, Grauer, Claudia, Brueckmann, Martina, Chernyatina, Marina, Donnan, Geoffrey, Ferro, José M, Grond, Martin, Kallmünzer, Bernd, Krupinski, Jerzy, Lee, Byung-Chul, Lemmens, Robin, Masjuan, Jaime, Odinak, Miroslav, Saver, Jeffrey L, Schellinger, Peter D, Toni, Danilo, Toyoda, Kazunori

Volltext

Dabigatran versus warfarin in patients with mechanical heart valves: reply von Eikelboom, J. W., Brueckmann, M., Werf, F.

Volltext

Empagliflozin after Acute Myocardial Infarction von Butler, Javed, Jones, W. Schuyler, Udell, Jacob A., Anker, Stefan D., Petrie, Mark C., Harrington, Josephine, Mattheus, Michaela, Zwiener, Isabella, Amir, Offer, Bahit, M. Cecilia, Bauersachs, Johann, Bayes-Genis, Antoni, Chen, Yundai, Chopra, Vijay K., Figtree, Gemma, Ge, Junbo, Goodman, Shaun G., Gotcheva, Nina, Goto, Shinya, Gasior, Tomasz, Jamal, Waheed, Januzzi, James L., Jeong, Myung Ho, Lopatin, Yuri, Lopes, Renato D., Merkely, Béla, Parikh, Puja B., Parkhomenko, Alexander, Ponikowski, Piotr, Rossello, Xavier, Schou, Morten, Simic, Dragan, Steg, P. Gabriel, Szachniewicz, Joanna, van der Meer, Peter, Vinereanu, Dragos, Zieroth, Shelley, Brueckmann, Martina, Sumin, Mikhail, Bhatt, Deepak L., Hernandez, Adrian F.

Volltext

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves von Eikelboom, John W, Connolly, Stuart J, Brueckmann, Martina, Granger, Christopher B, Kappetein, Arie P, Mack, Michael J, Blatchford, Jon, Devenny, Kevin, Friedman, Jeffrey, Guiver, Kelly, Harper, Ruth, Khder, Yasser, Lobmeyer, Maximilian T, Maas, Hugo, Voigt, Jens-Uwe, Simoons, Maarten L, Van de Werf, Frans

Volltext

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin von Majeed, Ammar, Hwang, Hun-Gyu, Connolly, Stuart J, Eikelboom, John W, Ezekowitz, Michael D, Wallentin, Lars, Brueckmann, Martina, Fraessdorf, Mandy, Yusuf, Salim, Schulman, Sam

Volltext

Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer von Brueckmann, M, Borggrefe, M

Volltext

Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial von Douketis, James D, Healey, Jeff S, Brueckmann, Martina, Eikelboom, John W, Ezekowitz, Michael D, Fraessdorf, Mandy, Noack, Herbert, Oldgren, Jonas, Reilly, Paul, Spyropoulos, Alex C, Wallentin, Lars, Connolly, Stuart J

Volltext

Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality: Insights From the EMPA-REG OUTCOME Trial von Savarese, Gianluigi, Sattar, Naveed, Januzzi, James, Verma, Subodh, Lund, Lars H, Fitchett, David, Zeller, Cordula, George, Jyothis T, Brueckmann, Martina, Ofstad, Anne Pernille, Inzucchi, Silvio E, Wanner, Christoph, Zinman, Bernard, Butler, Javed

Volltext

Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design von Savarese, Gianluigi, Settergren, Camilla, Schrage, Benedikt, Thorvaldsen, Tonje, Löfman, Ida, Sartipy, Ulrik, Mellbin, Linda, Meyers, Andrea, Farsani, Soulmaz Fazeli, Brueckmann, Martina, Brodovicz, Kimberly G., Vedin, Ola, Asselbergs, Folkert W., Dahlström, Ulf, Cosentino, Francesco, Lund, Lars H.

Volltext

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice von Huisman, Menno V., Lip, Gregory Y. H., Diener, Hans-Christoph, Brueckmann, Martina, van Ryn, Joanne, Clemens, Andreas

Volltext

Body mass index from the RE-LY trial: further evidence of the obesity paradox von Jacobs, M, Ezekowitz, M, Nagarakanti, R, Eikelboom, J, Khan, O, Reiss, J, Liu, H, McAndrew, T, Francese, D, Arce, J, Brueckmann, M, Connolly, S, Yusuf, S

Volltext

Association of heart rate with heart failure outcomes and the effects of empagliflozin in patients with preserved ejection fraction – EMPEROR-Preserved trial von Boehm, M, Anker, S D, Mahfoud, F, Filippatos, G, Ferreira, J P, Pocock, S J, Brueckmann, M, Linetzky, B, Schueler, E, Wanner, C, Zannad, F, Packer, M, Butler, J

Volltext

P2629Early benefits of empagliflozin in patients with type 2 diabetes with heart failure are not offset by increased adverse events: results from the EMPA-REG OUTCOME trial von Pellicori, P, Pernille Ofstad, A, Fitchett, D, Zeller, C, Wanner, C, George, J, Zinman, B, Brueckmann, M, Lindenfeld, J

Volltext

Abstract 66: Changes to the Cleft Nose Aesthetic After LeFort I Advancement: a 3D analysis von Ma, Irene T., Lee, Jonathan Y., Brueckmann, Loni M., Chow, Ian, Losee, Joseph E., Goldstein, Jesse A.

Volltext

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European... von Kirchhof, Paulus, Lip, Gregory Y.H., Van Gelder, Isabelle C., Bax, Jeroen, Hylek, Elaine, Kaab, Stefan, Schotten, Ulrich, Wegscheider, Karl, Boriani, Giuseppe, Brandes, Axel, Ezekowitz, Michael, Diener, Hans, Haegeli, Laurent, Heidbuchel, Hein, Lane, Deirdre, Mont, Luis, Willems, Stephan, Dorian, Paul, Aunes-Jansson, Maria, Blomstrom-Lundqvist, Carina, Borentain, Maria, Breitenstein, Stefanie, Brueckmann, Martina, Cater, Nilo, Clemens, Andreas, Dobrev, Dobromir, Dubner, Sergio, Edvardsson, Nils G., Friberg, Leif, Goette, Andreas, Gulizia, Michele, Hatala, Robert, Horwood, Jenny, Szumowski, Lukas, Kappenberger, Lukas, Kautzner, Josef, Leute, Angelika, Lobban, Trudie, Meyer, Ralf, Millerhagen, Jay, Morgan, John, Muenzel, Felix, Nabauer, Michael, Baertels, Christoph, Oeff, Michael, Paar, Dieter, Polifka, Juergen, Ravens, Ursula, Rosin, Ludger, Stegink, W., Steinbeck, Gerhard, Vardas, Panos, Vincent, Alphons, Walter, Maureen, Breithardt, Günter, Camm, A. John

Volltext

Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells von Brueckmann, Martina, Nahrup, Adriane Schulze, Lang, Siegfried, Bertsch, Thomas, Fukudome, Kenji, Liebe, Volker, Kaden, Jens J., Hoffmann, Ursula, Borggrefe, Martin, Huhle, Guenter

Volltext

286Predictors of atrial fibrillation in patients with embolic stroke of undetermined source: an analysis of the RE-SPECT ESUS trial von Granger, C B, Sacco, R L, Easton, J D, Meyerhoff, J, Cronin, L, Kleine, E, Grauer, C, Bahit, M C, Brueckmann, M, Diener, H.-C

Volltext